BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 30906372)

  • 1. 18F-FP-CIT Positron Emission Tomography for Correlating Motor and Cognitive Symptoms of Parkinson's Disease.
    Yang Y; Cheon M; Kwak YT
    Dement Neurocogn Disord; 2017 Sep; 16(3):57-63. PubMed ID: 30906372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlating Parkinson's disease motor symptoms with three-dimensional [(18)F]FP-CIT PET.
    Chung M; Park YS; Kim JS; Kim YJ; Ma HI; Jang SJ; Huh R; Kim HS; Kim WC
    Jpn J Radiol; 2015 Oct; 33(10):609-18. PubMed ID: 25952404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 18F-FP-CIT PET imaging and SPM analysis of dopamine transporters in Parkinson's disease in various Hoehn & Yahr stages.
    Wang J; Zuo CT; Jiang YP; Guan YH; Chen ZP; Xiang JD; Yang LQ; Ding ZT; Wu JJ; Su HL
    J Neurol; 2007 Feb; 254(2):185-90. PubMed ID: 17334953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An FP-CIT PET comparison of the difference in dopaminergic neuronal loss in subtypes of early Parkinson's disease.
    Song IU; Chung YA; Oh JK; Chung SW
    Acta Radiol; 2014 Apr; 55(3):366-71. PubMed ID: 23943629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics and influencing factors of
    Kangli F; Hongguang Z; Yinghua L; Xiaoxiao D; Yuyin D; Lulu G; Yi L; Zhihui S; Ying Z
    Front Neurol; 2023; 14():1195577. PubMed ID: 37483437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in nigro-striatal impairment in clinical variants of early Parkinson's disease: evidence from a FP-CIT SPECT study.
    Rossi C; Frosini D; Volterrani D; De Feo P; Unti E; Nicoletti V; Kiferle L; Bonuccelli U; Ceravolo R
    Eur J Neurol; 2010 Apr; 17(4):626-30. PubMed ID: 20050904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Right putamen and age are the most discriminant features to diagnose Parkinson's disease by using
    Cascianelli S; Tranfaglia C; Fravolini ML; Bianconi F; Minestrini M; Nuvoli S; Tambasco N; Dottorini ME; Palumbo B
    Hell J Nucl Med; 2017; 20 Suppl():165. PubMed ID: 29324935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 123I-FP-CIT SPECT imaging of dopamine transporters in patients with cerebrovascular disease and clinical diagnosis of vascular parkinsonism.
    Lorberboym M; Djaldetti R; Melamed E; Sadeh M; Lampl Y
    J Nucl Med; 2004 Oct; 45(10):1688-93. PubMed ID: 15471834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic motor cortex stimulation in patients with advanced Parkinson's disease and effects on striatal dopaminergic transmission as assessed by 123I-FP-CIT SPECT: a preliminary report.
    Di Giuda D; Calcagni ML; Totaro M; Cocciolillo F; Piano C; Soleti F; Fasano A; Cioni B; Bentivoglio AR; Giordano A
    Nucl Med Commun; 2012 Sep; 33(9):933-40. PubMed ID: 22735298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FP-CIT SPECT does not predict the progression of motor symptoms in Parkinson's disease.
    Hubbuch M; Farmakis G; Schaefer A; Behnke S; Schneider S; Hellwig D; Fassbender K; Kirsch CM; Dillmann U; Spiegel J
    Eur Neurol; 2011; 65(4):187-92. PubMed ID: 21412004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serial dopamine transporter imaging of nigrostriatal function in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study.
    Iranzo A; Valldeoriola F; Lomeña F; Molinuevo JL; Serradell M; Salamero M; Cot A; Ros D; Pavía J; Santamaria J; Tolosa E
    Lancet Neurol; 2011 Sep; 10(9):797-805. PubMed ID: 21802993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Striatal FP-CIT uptake differs in the subtypes of early Parkinson's disease.
    Spiegel J; Hellwig D; Samnick S; Jost W; Möllers MO; Fassbender K; Kirsch CM; Dillmann U
    J Neural Transm (Vienna); 2007 Mar; 114(3):331-5. PubMed ID: 16715205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presynaptic dopaminergic function in early-onset Alzheimer's disease: an FP-CIT image study.
    Jang H; Jang YK; Park S; Kim SE; Kim SJ; Cho SH; Youn J; Seo SW; Kim HJ; Na DL
    Neurobiol Aging; 2020 Feb; 86():75-80. PubMed ID: 31843258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of Parkinson's disease severity and duration with 123I-FP-CIT SPECT striatal uptake.
    Benamer HT; Patterson J; Wyper DJ; Hadley DM; Macphee GJ; Grosset DG
    Mov Disord; 2000 Jul; 15(4):692-8. PubMed ID: 10928580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [123I]beta-CIT SPECT demonstrates decreased brain dopamine and serotonin transporter levels in untreated parkinsonian patients.
    Haapaniemi TH; Ahonen A; Torniainen P; Sotaniemi KA; Myllylä VV
    Mov Disord; 2001 Jan; 16(1):124-30. PubMed ID: 11215571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between
    Terashi H; Taguchi T; Ueta Y; Mitoma H; Aizawa H
    J Neurol Sci; 2021 Jul; 426():117476. PubMed ID: 33975190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Test-retest reproducibility of dopamine transporter density measured with [
    Son HJ; Oh JS; Oh M; Lee SJ; Oh SJ; Chung SJ; Kim JS
    Ann Nucl Med; 2021 Mar; 35(3):299-306. PubMed ID: 33387281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is Parkinson's Disease with History of Agent Orange Exposure Different from Idiopathic Parkinson's Disease?
    Yang Y; Cheon M; Kwak YT
    Dement Neurocogn Disord; 2016 Sep; 15(3):75-81. PubMed ID: 30906346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Association of β-Amyloid with Cognition and Striatal Dopamine in Early, Non-Demented Parkinson's Disease.
    Oh YS; Yoo SW; Lyoo CH; Yoo JY; Yoon H; Ha S; Lee KS; Kim JS
    J Parkinsons Dis; 2021; 11(2):605-613. PubMed ID: 33646180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Additional Role of Midbrain F-18 FP-CIT Uptake on PET in Evaluation of Essential Tremor and Parkinsonism.
    Lee H; Sung YH; Hwang KH
    Curr Med Imaging; 2023; 19(9):1041-1051. PubMed ID: 36734891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.